4.6 Review

Basophils, IgE, and Autoantibody-Mediated Kidney Disease

Journal

JOURNAL OF IMMUNOLOGY
Volume 186, Issue 11, Pages 6083-6090

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1002648

Keywords

-

Categories

Funding

  1. National Institutes of Health [AI080908]

Ask authors/readers for more resources

Basophils are of interest in immunology due to their ability to produce a Th2-signature cytokine, IL-4, following activation. A new understanding of the role of basophils in immunity shows novel functions at a cellular level through which basophils influence adaptive immunity. This review summarizes new advances in basophil biology and discusses new roles for basophils in human disease, especially in the mediation of the pathogenesis of lupus nephritis. Recently, basophils have been shown to contribute to self-reactive Ab production in systemic lupus erythematosus and may enhance preexisting loss of B cell tolerance, suggesting that basophils, IL-4, and IgE mediate the pathogenesis of lupus nephritis by promoting the Th2 environment and activating autoreactive B cells. In addition to envisaging exciting therapeutic prospects, these novel findings open the way for the study of basophils in other autoimmune and renal diseases. The Journal of Immunology, 2011, 186: 6083-6090.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Rheumatology

Cost-effectiveness analysis of treatments for the first episode of catastrophic antiphospholipid syndrome: A study based on the catastrophic antiphospholipid syndrome registry

Gerardo Quintana-Lopez, Ignasi Rodriguez-Pinto, Kevin Maldonado-Canon, Gerard Espinosa, Jorge Diaz-Rojas, Ricard Cervera

Summary: This study evaluated the effectiveness and cost-effectiveness of different treatment schemes for CAPS. The results showed that scheme 2 was the most cost-effective strategy in the Colombian healthcare system.

LUPUS (2022)

Article Rheumatology

Patients with laboratory criteria of anti-phospholipid syndrome and 'non-criteria' manifestations: a multicenter cohort

G. Pires da Rosa, E. Ferreira, B. Sousa-Pinto, P. Bettencourt, G. Espinosa, R. Cervera

Summary: This study analyzed a cohort of patients with laboratory criteria for anti-phospholipid syndrome (APS) but only presenting "non-criteria" clinical manifestations. The patients were compared with definite APS patients. The results showed that these "clinical non-criteria" patients had mainly hematological and neurological involvements, with significant treatment use. Some patients may progress to future systemic lupus erythematosus (SLE).

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2023)

Article Rheumatology

The adjusted Global Anti-Phospholipid Syndrome Score as predictor of damage accrual measured by Damage Index for APS: a longitudinal study

Giuseppe Barilaro, Carlo Della Rocca, Alexandra Esteves, Ricard Cervera, Gerard Espinosa

Summary: This study analyzed the association between the average 'adjusted' Global APS Score (aGAPSS) and the change in Damage Index for APS (DIAPS) in patients with thrombotic and non-thrombotic APS. The results showed that a higher average aGAPSS value was associated with an increase in DIAPS during follow-up, suggesting that the average aGAPSS score can predict the increase in DIAPS.

RHEUMATOLOGY (2023)

Article Genetics & Heredity

Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

Martin Kerick, Marialbert Acosta-Herrera, Carmen Pilar Simeon-Aznar, Jose Luis Callejas, Shervin Assassi, Susanna M. Proudman, Mandana Nikpour, Nicolas Hunzelmann, Gianluca Moroncini, Jeska K. de Vries-Bouwstra, Gisela Orozco, Anne Barton, Ariane L. Herrick, Chikashi Terao, Yannick Allanore, Carmen Fonseca, Marta Eugenia Alarcon-Riquelme, Timothy R. D. J. Radstake, Lorenzo Beretta, Christopher P. Denton, Maureen D. Mayes, Javier Martin

Summary: This study investigated the association of C4 CN with systemic sclerosis risk, finding that higher C4 CN provides protection to SSc, while deviations from CN parity of C4A and C4B increase risk. Gender differences were observed in the protection conferred by C4A and C4B.

NPJ GENOMIC MEDICINE (2022)

Review Immunology

Chimeric antigen receptor-based therapies beyond cancer

Maria Velasco-de Andres, Guillermo Munoz-Sanchez, Laura Carrillo-Serradell, Maria del Mar Gutierrez-Hernandez, Cristina Catala, Marcos Isamat, Francisco Lozano

Summary: Adoptive cell transfer (ACT) therapies, especially those based on chimeric antigen receptor (CAR) technology, have gained significant attention in the field of immunotherapy. CAR-based ACT has shown successful results in treating hematological malignancies and has the potential to be effective in other tumors as well as immune-mediated disorders. This review discusses the results and limitations of preclinical and clinical studies in areas such as infection, allergy, autoimmunity, transplantation, and fibrotic repair.

EUROPEAN JOURNAL OF IMMUNOLOGY (2023)

Article Rheumatology

Preclinical ocular changes in systemic lupus erythematosus patients by optical coherence tomography

Laura Pelegrin, Montse Morato, Olga Araujo, Marc Figueras-Roca, Javier Zarranz-Ventura, Alfredo Adan, Ricard Cervera, Ricardo P. Casaroli-Marano, Vanesa Budi, Lucia Barrera-Lopez, Jose Rios, Jose Hernandez-Rodriguez, Gerard Espinosa

Summary: This study detected preclinical changes in retinal microvascularization and retinal and optical nerve structure in SLE patients using optical coherence tomography. The results showed that structural and perifoveal vascular parameters were decreased in SLE patients, especially in those with longer disease duration and higher disease damage. APS was associated with preclinical damage to the optic nerve and impairment of the perifoveal microvasculature.

RHEUMATOLOGY (2023)

Article Pharmacology & Pharmacy

Novel Tumor-Targeted Self-Nanostructured and Compartmentalized Water-in-Oil-in-Water Polyurethane-Polyurea Nanocapsules for Cancer Theragnosis

Joaquin Bonelli, Maria Velasco-de Andres, Neus Isidro, Cristina Bayo, Sergi Chumillas, Laura Carrillo-Serradell, Sergi Casado-Llombart, Cheryl Mok, Daniel Benitez-Ribas, Francisco Lozano, Josep Rocas, Vicente Marchan

Summary: This study reports a technology that encapsulates water-soluble bioactive compounds in double-walled polyurethane-polyurea hybrid nanocapsules (NCs) loaded with indocyanine green (ICG). The NCs demonstrate specific accumulation in tumor tissues while avoiding premature clearance in the bloodstream, making them promising for cancer theragnosis.

PHARMACEUTICS (2023)

Editorial Material Medicine, General & Internal

Mortality and causes of death in systemic lupus erythematosus revisited

Giuseppe Barilaro, Ricard Cervera

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Article Medicine, General & Internal

Heart Valve Involvement in Patients with Antiphospholipid Syndrome: A Long-Term Follow-Up Study of a Single Centre

Isaac Pons, Joana Louro, Marta Sitges, Barbara Vidal, Ricard Cervera, Gerard Espinosa

Summary: This study describes the prevalence, clinical and laboratory features, and evolution of heart valve involvement in patients with APS. The results showed that 50% of APS patients had valve involvement, with most of them being female and having arterial hypertension and arterial thrombosis. The valve involvement group had a higher mortality rate.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Medicine, General & Internal

Anti-dsDNA B-Cell ELISpot as a Monitoring and Flare Prediction Tool in SLE Patients

Albert Perez-Isidro, Marc Xipell, Arturo Llobell, Noemi De Moner, Gema M. Lledo, Ricard Cervera, Sergio Prieto-Gonzalez, Luis F. Quintana, Gerard Espinosa, Mila Garcia-Ormaechea, Estibaliz Ruiz-Ortiz, Odette Vinas

Summary: This study investigated whether dsDNA antibody-secreting B-cells could be a complementary biomarker for monitoring disease activity and prognosis in SLE patients. The results showed that SLE-ELISpot had the best performance in identifying active patients. High SLE-ELISpot results were associated with haematological involvement and increased risk of disease flare-up, especially renal flare. Combining hypocomplementemia and high SLE-ELISpot results further increased these risks. Therefore, adding SLE-ELISpot to the current follow-up protocol can improve clinicians' personalized care decisions.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Immunology

Hematological involvement in sarcoidosis: from cytopenias to lymphoma

Pilar Brito-Zeron, Elyse E. Lower, Manuel Ramos-Casals, Robert P. Baughman

Summary: This article provides an updated overview of the hematological involvement associated with sarcoidosis, including the management approach for cytopenias and the association with hematological malignancies. The etiology of cytopenias in sarcoidosis can be attributed to infiltration of hematopoietic organs and autoimmune-mediated cytopenias. The association between sarcoidosis and hematologic involvement is best understood as a pathogenic continuum, where cytopenias and hematologic neoplasms are intertwined due to various etiopathogenic mechanisms.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2023)

Editorial Material Rheumatology

Combination of old and new drugs to improve renal outcome in SLE patients

Gerard Espinosa, Ricard Cervera

RHEUMATOLOGY (2023)

Article Rheumatology

What do patients on methotrexate need and expect at the clinic? An online patient survey

Teresa Oton, Loreto Carmona, Jose Luis Andreu

Summary: This study assessed the experience and needs of patients receiving MTX treatment through an online survey. The results showed that patients were not satisfied with the quality of information provided by clinics and had a demand for more and better-quality written or web-based information.

RHEUMATOLOGY INTERNATIONAL (2023)

Meeting Abstract Rheumatology

Association Study Between anti-TIF1γ Antibody and Development of Neoplasia in Three Tertiary Hospitals

Marina Pavia Pascual, Isidro Jarque Canalias, Jose Luis Morell, Jesus Loarce Martos, Lorena Montano Tapia, Olga Rusinovich, Natalia de la Torre-Rubio, Maria Machattou, Pablo Navarro Palomo, Maria Carmen Barbadillo Mateos, Monica Fernandez Castro, Blanca Garcia-Magallon, Maria Hildegarda Godoy Tundidor, Carolina Merino, Jesus Sanz Sanz, Jose Luis Andreu, Jose Campos

ARTHRITIS & RHEUMATOLOGY (2022)

Article Rheumatology

The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study

Gilberto Pires da Rosa, Bernardo Sousa-Pinto, Ester Ferreira, Olga Araujo, Giuseppe Barilaro, Paulo Bettencourt, Ricard Cervera, Gerard Espinosa

Summary: Compared with the control group, the SN-APS group showed more thrombosis recurrence, indefinite anticoagulation, and use of VKA. The presence of these features may negatively impact the clinical course of patients with thrombosis and negative aPL.

ARTHRITIS RESEARCH & THERAPY (2022)

No Data Available